Temporal and spatial heterogeneity of programmed cell death 1-Ligand 1 expression in malignant mesothelioma
2017; Landes Bioscience; Volume: 6; Issue: 11 Linguagem: Inglês
10.1080/2162402x.2017.1356146
ISSN2162-402X
AutoresSimone Terra, Aaron S. Mansfield, Haidong Dong, Tobias Peikert, Anja C. Roden,
Tópico(s)Cancer Research and Treatments
Resumo: Programmed Cell Death 1-Ligand 1 (PD-L1) and Programmed Death Protein 1 (PD-1) blocking antibodies are promising immunotherapies for malignancies. We have previously shown PD-L1 expression in 40% of malignant mesothelioma (MM); however, the temporal and spatial heterogeneity of its expression has not been thoroughly studied. We compared PD-L1 expression between paired primary and metastatic MM.
Referência(s)